Inhibition of human 17beta-HSD4 expressed in Escherichia coli assessed as radiolabeled E1 formation using [6,7-3H]E2 as substrate at 1 uM by scintillation counting
Inhibition of human 17beta-HSD5 expressed in Escherichia coli assessed as radiolabeled testosterone formation using [1,2,6,7-3H]A-dione as substrate at 1 uM by scintillation counting
Inhibition of human placental cytosolic 17beta-HSD2 assessed as inhibition of E1 formation using [2,4,6,7-3H]E2 as substrate at 1 uM after 20 mins by HPLC analysis
Inhibition of human placental cytosolic 17beta-HSD2 assessed as inhibition of E1 formation using [2,4,6,7-3H]E2 as substrate at 100 nM after 20 mins by HPLC analysis
Inhibition of human placental cytosolic 17beta-HSD1 assessed as inhibition of E2 formation using [2,4,6,7-3H]E1 as substrate at 1 uM after 10 mins by HPLC analysis
Inhibition of human placental cytosolic 17beta-HSD1 assessed as inhibition of E2 formation using [2,4,6,7-3H]E1 as substrate at 100 nM after 10 mins by HPLC analysis
Inhibition of rat liver microsomal 17beta-HSD2 assessed as inhibition of E1 formation using [2,4,6,7-3H]E2 as substrate at 1 uM after 20 mins by HPLC analysis
Inhibition of rat liver microsomal 17beta-HSD1 assessed as inhibition of E2 formation using [2,4,6,7-3H]E1 as substrate at 1 uM after 10 mins by HPLC analysis
Inhibition of mouse liver microsomal 17beta-HSD2 assessed as inhibition of E1 formation using [2,4,6,7-3H]E2 as substrate at 1 uM after 20 mins by HPLC analysis
Inhibition of mouse liver microsomal 17beta-HSD1 assessed as inhibition of E2 formation using [2,4,6,7-3H]E1 as substrate at 1 uM after 10 mins by HPLC analysis
Inhibition of monkey placental microsomal 17beta-HSD2 assessed as inhibition of E1 formation using [2,4,6,7-3H]E2 as substrate at 1 uM after 10 mins by HPLC analysis
Inhibition of monkey placental microsomal 17beta-HSD2 assessed as inhibition of E1 formation using [2,4,6,7-3H]E2 as substrate at 100 nM after 10 mins by HPLC analysis